WebMay 20, 2024 · The acquisition is expected to close in the second quarter 2024. Opens new growth opportunities as Evotec diversifies into biologics. The acquisition of Just.Bio will add considerable business ... WebApr 10, 2024 · Just – Evotec Biologics is an integrated design company focused on technologies that accelerate the discovery and development of high quality … Just-Evotec Biologics has developed an integrated, continuous bioprocessing … Just – Evotec Biologics, Inc. 401 Terry Avenue Seattle, WA 98109 +1 206-651 … J.DESIGN Solutions Applying deep industry knowledge and breakthrough CDMO … J.POD ® Redmond, Washington (US) Redmond Ridge. 22857 NE Marketplace … In-person event where Just-Evotec Biologics will be participating in a panel … Just–Evotec Biologics will support the DOD with rapid, cost-efficient development of … Current methods for stably expressing biotherapeutics in CHO cells often rely … Download this poster presented at the 2024 International Conference on Antiviral …
Evotec SE provides update on cyber attack - Evotec
WebMay 20, 2024 · Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today the signing of a definitive agreement under which Evotec will acquire Just Biotherapeutics, Inc. (“Just.Bio”), for up to $ 90 m including potential performance-based earn-out components expected within the next three years. Just.Bio … WebJust Biotherapeutics is a fully owned subsidiary of Evotec, SE. President and CEO ... Global Head Biotherapeutics and President US Operations at Just - Evotec Biologics. Purdue University primates for sale in tn
Biotherapeutics - Evotec
WebHamburg, Germany, – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) announces that on 06 April, 2024 a cyber attack occurred on Evotec‘s IT systems. As a result, the systems were shut down proactively and disconnected from the Internet to secure from data corruption or breaches. WebMay 20, 2024 · Hamburg, Germany, 20 May 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today the signing of a definitive agreement under which Evotec will acquire Just Biotherapeutics, Inc. ("Just.Bio"), for up to $ 90 m including potential performance-based earn-out components expected within … WebApr 7, 2024 · Just is seeking an entry-level manufacturing Process Engineer with a passion for improving worldwide access to biotherapeutics. This team member will be engaged in designing, building, and implementing leading-edge technologies from the ground up. This role requires close collaboration with multi-disciplinary project/technical teams as we … primates have stereoscopic vision